Farringdon Capital, Ltd. Quest Diagnostics Inc Transaction History
Farringdon Capital, Ltd.
- $242 Billion
- Q4 2024
A detailed history of Farringdon Capital, Ltd. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 3,763 shares of DGX stock, worth $515,869. This represents 0.23% of its overall portfolio holdings.
Number of Shares
3,763Holding current value
$515,869% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding DGX
# of Institutions
980Shares Held
98.7MCall Options Held
417KPut Options Held
310K-
Vanguard Group Inc Valley Forge, PA14MShares$1.91 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.49MShares$753 Million0.1% of portfolio
-
State Street Corp Boston, MA5.22MShares$716 Million0.03% of portfolio
-
Victory Capital Management Inc3.36MShares$461 Million0.48% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...